Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin 800 mg four-way crossover bioavailability study in healthy adults
NL-OMON25575Active, not recruiting
- Sponsor
- Maastricht University Medical Center+
- Start
- Sep 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of gabapentin in epilepsy, sponsored by Maastricht University Medical Center+. Primary endpoints: AUC0-t bioequivalence comparison, AUCinf bioequivalence comparison and 1 more. Started Sep 2011; status: active, not recruiting.
02
Drugs
gabapentin
03
Conditions
epilepsy
Beyond the preview
Go deeper on NL-OMON25575.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25575.